Relationship between cognitive functioning and frailty in older breast cancer survivors.
暂无分享,去创建一个
Alexandra M. Gaynor | T. Traina | J. Root | T. Ahles | Yuelin Li | E. Schofield | Sunita K. Patel | A. Hurria | V. Katheria | J. Vazquez | Elizabeth L. Ryan | Katrazyna McNeal | Heidi Tan
[1] H. Cohen,et al. Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study. , 2021, Journal of the National Cancer Institute.
[2] S. Mohile,et al. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer , 2019, Journal of the American Geriatrics Society.
[3] A. Wolff,et al. Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer , 2019, Journal of the American Geriatrics Society.
[4] T. Ahles,et al. Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus , 2019, Molecular Neurobiology.
[5] J. VanMeter,et al. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Cohen,et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Root,et al. Cognitive Effects of Cancer and Cancer Treatments. , 2018, Annual review of clinical psychology.
[8] David Smith,et al. Frailty as determined by a comprehensive geriatric assessment‐derived deficit‐accumulation index in older patients with cancer who receive chemotherapy , 2016, Cancer.
[9] H. Cohen,et al. Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) , 2016, Cancer.
[10] L. Ercoli,et al. Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient’s assessment of own functioning inventory , 2016, Supportive Care in Cancer.
[11] T. Ahles,et al. Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways , 2015, Behavioural Brain Research.
[12] Jeanne S Mandelblatt,et al. Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Christopher M. Nguyen,et al. Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions , 2013, Psycho-Oncology.
[14] C. Gundy,et al. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Supriya G Mohile,et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Nathaniel Mercaldo,et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.
[17] Andrew J. Saykin,et al. Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.
[18] J. Holland,et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective , 2006, Breast Cancer Research and Treatment.
[19] L. Gavrilov,et al. The Reliability‐Engineering Approach to the Problem of Biological Aging , 2004, Annals of the New York Academy of Sciences.
[20] Cynthia Owsley,et al. Timed Instrumental Activities of Daily Living Tasks: Relationship to Cognitive Function and Everyday Performance Assessments in Older Adults , 2002, Gerontology.
[21] Elizabeth H Bradley,et al. Understanding the treatment preferences of seriously ill patients. , 2002, The New England journal of medicine.
[22] Andrew J Saykin,et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Katzman.,et al. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. , 1983, The American journal of psychiatry.
[24] G. Fillenbaum,et al. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.
[25] L. Radloff. The CES-D Scale , 1977 .
[26] Arthur L. Benton,et al. Differential behavioral effects in frontal lobe disease , 1968 .
[27] D. Cox,et al. An Analysis of Transformations , 1964 .
[28] A. Mitnitski,et al. Aging as a process of deficit accumulation: its utility and origin. , 2015, Interdisciplinary topics in gerontology.
[29] S. Schultz,et al. Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. , 2010, The Journal of neuropsychiatry and clinical neurosciences.
[30] W. Sturm,et al. Neuropsychological assessment , 2007, Journal of Neurology.
[31] P. Jacobsen,et al. Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancer , 2005, Supportive Care in Cancer.